{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T00:26:38Z","timestamp":1791851198015,"version":"4.3.4"},"reference-count":22,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"8","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2005,11]]},"DOI":"10.1097\/01.mbc.0000186837.78432.2f","type":"journal-article","created":{"date-parts":[[2005,11,2]],"date-time":"2005-11-02T04:01:10Z","timestamp":1130904070000},"page":"549-555","source":"Crossref","is-referenced-by-count":51,"title":["Control of bleeding in children with Dengue hemorrhagic fever using recombinant activated factor VII: a randomized, double-blind, placebo-controlled study"],"prefix":"10.1097","volume":"16","author":[{"given":"Ampaiwan","family":"Chuansumrit","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Somporn","family":"Wangruangsatid","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yujinda","family":"Lektrakul","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mary Ng","family":"Chua","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria Rosario Zeta","family":"Capeding","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ole Molskov","family":"Bech","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-3-20210203","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/S0955-3886(98)00026-5","article-title":"Clinical use of recombinant FVIIa (rFVIIa)","volume":"19","author":"Hedner","year":"1998","journal-title":"Transfus Sci"},{"key":"R2-3-20210203","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1055\/s-2000-8453","article-title":"Recombinant coagulation factor VIIa: from the concept to clinical application in hemophilia treatment in 2000","volume":"26","author":"Hedner","year":"2000","journal-title":"Semin Thromb Hemost"},{"key":"R3-3-20210203","doi-asserted-by":"crossref","first-page":"722","DOI":"10.1097\/00000542-200403000-00036","article-title":"Current concepts of hemostasis: implications for therapy","volume":"100","author":"Roberts","year":"2004","journal-title":"Anesthesiology"},{"key":"R4-3-20210203","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1055\/s-2000-8463","article-title":"Efficacy and safety of recombinant factor VIIa in the prophylaxis of bleeding in various surgical procedures in hemophilic patients with factor VIII and factor IX inhibitors","volume":"26","author":"Ingerslev","year":"2000","journal-title":"Semin Thromb Hemost"},{"key":"R5-3-20210203","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1016\/j.arth.2004.01.015","article-title":"Total hip arthroplasty in severe congenital factor VII deficiency","volume":"20","author":"Niikura","year":"2005","journal-title":"J Arthroplasty"},{"key":"R6-3-20210203","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1080\/10245330400018581","article-title":"Recombinant activated factor VII in patients at high risk of bleeding","volume":"9","author":"Kubisz","year":"2004","journal-title":"Hematology (Netherlands)"},{"key":"R7-3-20210203","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1111\/j.1538-7836.2005.01127.x","article-title":"The effect of platelets on fibrin gel structure formed in the presence of recombinant factor VIIa in hemophilia plasma and in plasma from a patient with Glanzmann thrombasthenia","volume":"3","author":"He","year":"2005","journal-title":"J Thromb Hemost"},{"issue":"Suppl 1","key":"R8-3-20210203","doi-asserted-by":"crossref","first-page":"S121","DOI":"10.1097\/00001721-200004001-00023","article-title":"Effect of the administration of recombinant activated factor VII (rFVIIa; NovoSeven) in the management of severe uncontrolled bleeding in patients undergoing heart valve replacement surgery","volume":"11","author":"Al Douri","year":"2000","journal-title":"Blood Coagul Fibrinolysis"},{"key":"R9-3-20210203","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1016\/S0002-9343(99)00398-8","article-title":"Treatment of a severely bleeding patient without preexisting coagulopathy with activated recombinant factor VII","volume":"108","author":"Vlot","year":"2000","journal-title":"Am J Med"},{"key":"R10-3-20210203","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/S0140-6736(03)12268-4","article-title":"Effect of recombinant activated factor VII on perioperative blood loss in patients undergoing retropubic prostatectomy: a double-blind placebo-controlled randomised trial","volume":"361","author":"Friederich","year":"2003","journal-title":"Lancet"},{"key":"R11-3-20210203","doi-asserted-by":"crossref","first-page":"S221","DOI":"10.1007\/s00134-002-1468-2","article-title":"Treatment of critical bleeding in the future intensive care unit","volume":"28","author":"Goodnough","year":"2002","journal-title":"Intensive Care Med"},{"key":"R12-3-20210203","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1056\/NEJMoa042991","article-title":"Recombinant activated factor VII for acute intracerebral hemorrhage","volume":"352","author":"Mayer","year":"2005","journal-title":"N Engl J Med"},{"key":"R13-3-20210203","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1097\/01.CCM.0000159087.85970.38","article-title":"Efficacy and safety of recombinant factor VIIa for treatment of severe bleeding: a systematic review","volume":"33","author":"Levi","year":"2005","journal-title":"Crit Care Med"},{"key":"R14-3-20210203","doi-asserted-by":"crossref","first-page":"884","DOI":"10.7326\/0003-4819-137-11-200212030-00009","article-title":"Reversal of warfarin induced excessive anticoagulation with recombinant factor VIIa concentrate","volume":"137","author":"Deveras","year":"2002","journal-title":"Ann Intern Med"},{"key":"R15-3-20210203","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1097\/00001721-200307000-00007","article-title":"Reversal of the International Normalized Ratio with recombinant activated factor VII in central nervous system bleeding during warfarin thromboprophylaxis: clinical and biochemical aspects","volume":"14","author":"Sorensen","year":"2003","journal-title":"Blood Coagul Fibrinolysis"},{"key":"R17-3-20210203","first-page":"193","article-title":"Dengue\/dengue haemorrhagic fever.","volume":"75","year":"2000","journal-title":"Weekly Epidemiological Record"},{"key":"R20-3-20210203","doi-asserted-by":"crossref","first-page":"975","DOI":"10.4269\/ajtmh.1977.26.975","article-title":"Hemostatic and platelet kinetic studies in dengue hemorrhagic fever","volume":"26","author":"Mitrakul","year":"1977","journal-title":"Am J Trop Med Hyg"},{"key":"R21-3-20210203","first-page":"331","article-title":"Hemostatic derangement in dengue hemorrhagic fever","volume":"18","author":"Isarangkura","year":"1987","journal-title":"Southeast Asian J Trop Med Public Health"},{"key":"R22-3-20210203","first-page":"24","article-title":"Studies on serum complement C3 and fibrinogen degradation product in Thai hemorrhagic fever","volume":"56","author":"Suvatte","year":"1973","journal-title":"J Med Assoc Thai"},{"key":"R23-3-20210203","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1086\/341410","article-title":"Coagulation abnormalities in dengue hemorrhagic fever: serial investigations in 167 Vietnam children with dengue shock syndrome","volume":"35","author":"Willis","year":"2002","journal-title":"Clin Infect Dis"},{"key":"R24-3-20210203","doi-asserted-by":"crossref","first-page":"840","DOI":"10.4269\/ajtmh.2001.65.840","article-title":"Mechanism of hemorrhage in dengue without circulatory collapse","volume":"65","author":"Krishnamurit","year":"2001","journal-title":"Am J Trop Med Hyg"},{"key":"R25-3-20210203","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1055\/s-2000-8457","article-title":"Pharmacokinetics of recombinant activated factor VII (rFVIIa)","volume":"26","author":"Erhardtsen","year":"2000","journal-title":"Semin Thromb Hemost"}],"container-title":["Blood Coagulation & Fibrinolysis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/01241398-200511000-00009","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,6]],"date-time":"2026-08-06T18:01:23Z","timestamp":1786039283000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/00001721-200511000-00003"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,11]]},"references-count":22,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2005]]}},"URL":"https:\/\/doi.org\/10.1097\/01.mbc.0000186837.78432.2f","relation":{},"ISSN":["0957-5235"],"issn-type":[{"value":"0957-5235","type":"print"}],"subject":[],"published":{"date-parts":[[2005,11]]}}}